Aller au contenu principal
Profil bibliographique

Valerie W. Rusch

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

1085Publications signalées
106432Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsOccupational and environmental lung diseasesPleural and Pulmonary DiseasesEsophageal Cancer Research and Treatment

Les publications récentes

2026 article OpenAlex

Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non–Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART)

Andreas Rimner, Emily S. Lebow, Kelly Fitzgerald, Leah B. Kratochvil et autres

PURPOSE: Concurrent platinum-based chemotherapy and radiation therapy (cCRT) followed by consolidative durvalumab is the standard of care (SoC) for fit patients with inoperable, locally advanced non-small cell lung cancer (LA-NSCLC). However, no SoC exists for patients who are cCRT-ineligible because of age, …

us, de (code pays fourni par la source)

1 citation Journal of Clinical Oncology
Accès ouvert 2026 article OpenAlex

Minimally invasive surgical techniques for oncologic resections: A multi-specialty experience within a high-volume center

Kevin C. Soares, Rachel N. Harvey, Rubiya Haque, Junting Zheng et autres

Background Minimally invasive surgery (MIS) is prevalent in surgical oncology. While some studies suggest that MIS is associated with perioperative benefits and comparable oncologic outcomes, more recent studies in robotic surgery dispute these findings. We aim to assess perioperative and oncologic outcomes …

us (code pays fourni par la source)

0 citations Surgical Oncology Insight
Accès ouvert 2026 article OpenAlex

Feasibility and oncologic outcomes of minimally invasive surgery after induction chemoimmunotherapy for non–small cell lung cancer

Giovanni M. Comacchio, Marisa Sewell, Kay See Tan, Nicolas Toumbacaris et autres

Objective We evaluated the feasibility and long-term outcomes of minimally invasive surgery (MIS) after neoadjuvant immunotherapy in patients with resectable non–small cell lung cancer (NSCLC). Methods Patients with stage IB-IIIB NSCLC who underwent induction immunotherapy followed by surgery (2015-2022) were included. Overall …

us (code pays fourni par la source)

1 citation JTCVS Open
Accès ouvert 2025 erratum OpenAlex

Corrigendum to “The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database. [Journal of Thoracic Oncology Vol. 20 No. 10: 1423–1440]”

David P. Carbone, Fred R Hirsch, Raymond Uyiosa Osarogiagbon, Katherine K. Nishimura et autres

us, ca, cn, jp, br, gb, es (code pays fourni par la source)

0 citations Journal of Thoracic Oncology
Accès ouvert 2025 conference-abstract OpenAlex

510 Dynamic tumor and immune response to neoadjuvant nivolumab with chemotherapy in diffuse pleural mesothelioma

Yonit Lavin, Matthew Zatzman, Jennifer L. Sauter, Nataly Naser Al Deen et autres

Background Diffuse pleural mesothelioma (DPM) is an aggressive malignancy with poor outcomes even in potentially resectable disease. With an evolving understanding of the role of pleurectomy/decortication (P/D) in patients with resectable disease, the need to optimize and improve upfront therapies is more …

us (code pays fourni par la source)

0 citations Regular and Young Investigator Award Abstracts

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.